Biocompatibility evaluation of different alginates and alginate-based microcapsules

Area of Science:

• Biomaterials Science
• Biotechnology
• Medical Device Development

Background:

• Biocompatibility is crucial for long-term function of biomaterials and medical devices.
• There is a growing demand for biocompatible materials and improved quality assessment assays.
• Alginates are widely used in therapeutic systems, necessitating rigorous biocompatibility testing.

Purpose of the Study:

• To present a comprehensive battery of in vitro techniques for assessing alginate biocompatibility.
• To evaluate differences in biocompatibility between purified and non-purified alginates.
• To assess the biocompatibility of alginate-based microcapsules using adapted assays.

Main Methods:

• Analysis of protein and polyphenol content in alginates.
• Assessment of mitogenic activity induced by alginates.
• Measurement of tumor necrosis factor-alpha secretion.
• Adaptation of assays for evaluating alginate-based microcapsules.

Main Results:

• Significant differences in protein and polyphenol content were found between purified and non-purified alginates.
• Purified alginates exhibited distinct mitogenic activity and induced less tumor necrosis factor-alpha secretion.
• Assays adapted for microcapsules showed results correlating with those of the alginate samples.

Conclusions:

• The presented battery of in vitro assays effectively differentiates alginate biocompatibility.
• Purification significantly enhances the biocompatibility of alginates.
• These assays provide a reliable method for screening alginates and microcapsules prior to implantation.